ReceptorBio

Receptor Bio is an early-stage biotechnology company based in San Francisco, focused on developing a proprietary platform for the discovery of high-affinity and high-specificity binders to cell surface receptors. The company specifically targets challenging receptor classes, such as G protein-coupled receptors (GPCRs), which are critical in various disease pathways but often difficult to drug with traditional methods. Founded by experienced industry leaders from MorphoSys, Receptor Bio leverages advanced protein engineering and screening technologies to generate novel therapeutic candidates. Their approach aims to address unmet needs in therapeutic areas including oncology, immunology, and inflammatory diseases. The company is currently operating in a discovery-focused, pre-clinical stage.